BioPhoT invites you to an analytical webinar on the results of the second call's industry expert panel, project performance evaluation and key insights on the path to market for research ideas. The seminar will take place on 24 February at 14.00 at the Science and...

On 10 February, the Latvian Academy of Sciences (LAS) presented the results of the first year of operation of the BioPhoT research platform. Since the launch of the platform, 223 research and innovation project (RIP) applications have been received during the two...

Photo: Ilze Kuzmina Author of text: Ilze Kuzmina (Latvian Radio News Service correspondent) In the coming years, a vaccine created by the company Pfizer against tick-borne Lyme disease could appear on the pharmaceutical market. Meanwhile, research continues at the...

11 February marks the International Day of Women and Girls in Science. For more than a decade, this day has highlighted the significant contributions of women and girls to the advancement of science and technology. At the Latvian Biomedical Research and Study Centre,...

One of the key challenges in regenerative medicine today is the safe, scalable, and cost-effective production of extracellular vesicles (EVs). EVs are small, naturally released biological particles that play a crucial role in cell-to-cell communication and are widely...

In the photo: OSI Leading Researcher Dr. Alons Lends and Dr. Enrico Ravera next to the 800 MHz NMR spectrometer. On 4 February 2026, within the framework of the H2020 Twinning project MR LATVIA, a seminar entitled “Metalloproteins and Their Interactions Studied by...

4 February is marked as World Cancer Day. BBMRI-ERIC has prepared informative materials and aims to highlight members of the BBMRI-ERIC community who are contributing to the advancement of cancer research. The spotlight is on researchers and biobank professionals...

A substantial number of studies demonstrate that cancer-derived extracellular vesicles (EVs) promote cancer development by triggering various signal transduction pathways in recipient cells. Here, we propose to develop a conceptually novel liquid biopsy for the...

Please join us for a webinar hosted by Zaz Ventures, a leading strategic fundraising advisor for deep-tech companies. Based on years of experience, Zaz Ventures will offer insights into the 2026 funding landscape. The webinar will not only explain the “rules” - Zaz...

On 27 January 2026, the Latvian Biomedical Research and Study Centre was visited by researchers from Lithuania — Jonas Juozapaitis, Goda Grigorianaitė, and Dovilė Juozapaitė, representing the sequencing company SeqVision. All three researchers are also PhD candidates...

On 9 January 2026, the 3rd Conference on Structural Biology was held at Ratnieki, a property of the University of Latvia , with the support of Instruct-LV. At the opening of the conference, Professor Kaspars Tārs presented an overview of the latest activities of the...

Yesterday, “BioPhoT” Industry Day 2026 took place at the Science House of the University of Latvia, bringing together researchers, industry representatives, and investors to foster collaboration between science and business. During the event, memoranda of cooperation...

On 26 January, the University of Latvia (UL) Academic Centre Science House in Riga will host the Industry Day of the long-term national research programme “BioPhoT”. During the event, you will have the opportunity to get acquainted with current BioPhoT-funded...

The JA PCM kick-off meeting took place in Brussels on 14–15 January, bringing together 29 European countries and over 140 partner organisations to advance personalised cancer care across Europe. JA PCM aims to build a sustainable cross-border network that fosters...

On January 14ht-15th Joint Action Personalized Cancer Medicine (JA-PCM) kick-off meeting took place in Brussels. Latvian Biomedical Research and Study Centre is competent authority for JA-PCM implementation in Latvia. Coordinating and implementing this project in...